Macrophage type-I and type-II class-A scavenger receptors (MSR-A) are implicated in the pathological deposition of cholesterol during atherogenesis as a result of receptor-mediated uptake of modified low-density lipoproteins (mLDL). MSR-A can bind an extraordinarily wide range of ligands, including bacterial pathogens, and also mediates cation-independent macrophage adhesion in vitro. Here we show that targeted disruption of the MSR-A gene in mice results in a reduction in the size of atherosclerotic lesions in an animal deficient in apolipoprotein E. Macrophages from MSR-A-deficient mice show a marked decrease in mLDL uptake in vitro, whereas mLDL clearance from plasma occurs at a normal rate, indicating that there may be alternative mechanisms for removing mLDL from the circulation. In addition, MSR-A-knockout mice show an increased susceptibility to infection with Listeria monocytogenes or herpes simplex virus type-1, indicating that MSR-A may play a part in host defence against pathogens.
Familial Alzheimer disease mutations of presenilin 1 (PS-1) enhance the generation of A beta1-42, indicating that PS-1 is involved in amyloidogenesis. However, PS-1 transgenic mice have failed to show amyloid plaques in their brains. Because PS-1 mutations facilitate apoptotic neuronal death in vitro, we did careful quantitative studies in PS-1 transgenic mice and found that neurodegeneration was significantly accelerated in mice older than 13 months (aged mice) with familial Alzheimer disease mutant PS-1, without amyloid plaque formation. However, there were significantly more neurons containing intracellularly deposited A beta42 in aged mutant transgenic mice. Our data indicate that the pathogenic role of the PS-1 mutation is upstream of the amyloid cascade.
Streptozotocin (STZ), a glucose analogue known to induce diabetes in experimental animals, causes DNA strand breaks and subsequent activation of poly(ADPribose) polymerase (Parp). Because Parp uses NAD as a substrate, extensive DNA damage will result in reduction of cellular NAD level. In fact, STZ induces NAD depletion and cell death in isolated pancreatic islets in vitro. Activation of Parp therefore is thought to play an important role in STZ-induced diabetes. In the present study, we established Parp-deficient (Parp ؊/؊ ) mice by disrupting Parp exon 1 by using the homologous recombination technique. These mice were used to examine the possible involvement of Parp in STZ-induced -cell damage in vivo. The wild-type (Parp ؉/؉ ) mice showed significant increases in blood glucose concentration from 129 mg͞dl to 218, 370, 477, and 452 mg͞dl on experimental days 1, 7, 21, and 60, respectively, after a single injection of 180 mg STZ͞kg body weight. In contrast, the concentration of blood glucose in Parp ؊/؊ mice remained normal up to day 7, slightly increased on day 21, but returned to normal levels on day 60. STZ injection caused extensive necrosis in the islets of Parp ؉/؉ mice on day 1, with subsequent progressive islet atrophy and loss of functional  cells from day 7. In contrast, the extent of islet -cell death and dysfunction was markedly less in Parp ؊/؊ mice. Our findings clearly implicate Parp activation in islet -cell damage and glucose intolerance induced by STZ in vivo.Various types of DNA damage produced by many environmental chemicals or reactive oxygen species generated by inflammatory reactions contribute to insulin-dependent diabetes mellitus (IDDM) through the induction of -cell death in pancreatic islets (1-3). Acute exposure to streptozotocin [2-deoxy-2-(3-methyl-3-nitrosourea)l-D-glucopyranose, STZ] induces massive -cell death and diabetes mellitus in experimental animals (4, 5). STZ also causes a rapid depletion of cellular NAD in islets (6-9), but this depletion is prevented by injection of nicotinamide immediately before or soon after the administration of STZ (10). Okamoto and colleagues (2, 11) demonstrated that STZ induces DNA strand breaks and activation of poly(ADP-ribose) polymerase (Parp) with subsequent reduction of NAD levels in the isolated pancreatic islets in vitro. These findings suggest the involvement of Parp as a key molecule in STZ-induced -cell death and diabetes through extensive poly(ADP-ribose) formation and NAD depletion, leading to reduction of ATP level and cell death. In agreement with this hypothesis, Parp inhibitors such as 3-aminobenzamide or nicotinamide prevent the depletion of NAD and induction of STZ-induced -cell death (12, 13). However, because Parp inhibitors possess other effects, such as scavenging hydrogen peroxide (14), it is not clear whether and how Parp activity contributes to -cell death and the development of diabetes in vivo. Thus, engineering of a Parp-deficient animal model would be useful for investigating the role of Parp in S...
␣-Tocopherol transfer protein (␣-TTP), a cytosolic protein that specifically binds ␣-tocopherol, is known as a product of the causative gene in patients with ataxia that is associated with vitamin E deficiency. Targeted disruption of the ␣-TTP gene revealed that ␣-tocopherol concentration in the circulation was regulated by ␣-TTP expression levels. Male ␣-TTP ؊/؊ mice were fertile; however, placentas of pregnant ␣-TTP ؊/؊ females were severely impaired with marked reduction of labyrinthine trophoblasts, and the embryos died at mid-gestation even when fertilized eggs of ␣-TTP ؉/؉ mice were transferred into ␣-TTP ؊/؊ recipients. The use of excess ␣-tocopherol or a synthetic antioxidant (BO-653) dietary supplement by ␣-TTP ؊/؊ females prevented placental failure and allowed full-term pregnancies. In ␣-TTP ؉/؉ animals, ␣-TTP gene expression was observed in the uterus, and its level transiently increased after implantation (4.5 days postcoitum). Our results suggest that oxidative stress in the labyrinth region of the placenta is protected by vitamin E during development and that in addition to the hepatic ␣-TTP, which governs plasma ␣-tocopherol level, the uterine ␣-TTP may also play an important role in supplying this vitamin.Vitamin E (␣-tocopherol) is the most potent lipid-soluble antioxidant in biological membranes, where it contributes to membrane stability. Patients with ataxia and isolated vitamin E deficiency (AVED) 1 have low or undetectable serum vitamin E concentrations and exhibit neurological dysfunction and muscular weakness. It is now established that ␣-tocopherol transfer protein (␣-TTP), a cytosolic liver protein known to specifically bind to ␣-tocopherol (1), is defective in AVED patients (2), indicating that ␣-TTP is a major determinant of plasma ␣-tocopherol level. Although ␣-tocopherol was initially identified as an anti-sterility factor to prevent abortion (3), the mechanism of action and the molecules responsible for its antisterility effect remain unknown. One of the reasons for this is that vitamin E is difficult to deplete from tissues and requires elaborate manipulations to cause deficiency symptoms to occur in experimental animals. In this study, we established a mouse model lacking ␣-TTP by targeted mutagenesis. This animal model for human AVED patients is suitable for examination of the complex pathophysiology of diseases associated with vitamin E deficiency and/or caused by oxidative stress. Here we examined the role of ␣-TTP in pregnancy and embryogenesis using our new animal model. MATERIALS AND METHODSGeneration of ␣-TTP Knockout Mice-An ␣-TTP targeting vector was constructed from an 8.8-kb ␣-TTP genome fragment encompassing exon 1. We inserted a fragment of PGK-neo cassette into the SmaI-SmaI site positioned 5Ј and 3Ј to exon 1 and flanked a 1.8-kb fragment of HSV-tk gene downstream of exon 2. AB2.2-Prime ES cells (Lexicon Genetics) or A3-1 ES (4) cells were transfected by electroporation with a linearized targeting vector. G418/gancyclovir-resistant clones were screened by PCR, and...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.